A new study from Karolinska Institutet and Mayo Clinic has revealed important insights into brain degeneration in dementia with Lewy bodies (DLB). This research, published in JAMA Neurology ...
New research uncovers how declining protein clearance mechanisms with age lead to Alzheimer’s, Parkinson’s, and other ...
Now, a new study from Renmin Hospital of Wuhan University provides strong evidence that kidney failure may also contribute to the development of Parkinson’s disease by triggering the spread of ...
Sue's Story: A Journey with Lewy Body Dementia has been presented in Continuing Medical Education programs offered by Kaiser Permanente and other health systems; in nursing programs offered by ...
Stop the Spread. Injecting saline into mouse kidneys did not affect the left or right substantia nigra (top). Injecting fibrils of α-synuclein ablated about half of the dopaminergic neurons (middle ...
Data from the first 16 weeks of the open-label extension phase of the RewinD-LB trial are expected in 1Q 2025 and will include data from ...
The details of the presentation will be accessible in the Investor section of the CervoMed website following the presentation. CervoMed Inc. is a clinical-stage company focused on developing ...
The initial topline results for the Phase 2b study of neflamapimod in dementia with Lewy bodies (DLB ... orally administered small molecule brain penetrant designed to inhibit p38 mitogen ...
Jan. 28, 2025 /PRNewswire/ -- Today, the Susan and Charles Berghoff Foundation announced the public release of its award-winning documentary film, Sue's Story: A Journey with Lewy Body Dementia ...